secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q32 Bio Inc. (QTTB)
CIK:        0001661998
Form:       8-K
Filed at:   2026-06-16T20:01:35+00:00
Accession:  0001193125-26-272562
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Q32 Bio stockholders elect Class II directors, ratify auditor, approve say-on-pay at 2026 annual meeting
--------------------------------------------------------------------------------

- Stockholders elected Kathleen LaPorte, Jodie Morrison, and Arthur Tzianabos as Class II directors for three-year terms ending 2029.
- Ratification of Ernst & Young as independent auditor for FY 2026 passed with 11,821,046 votes for, 7,909 against.
- Non-binding advisory vote on named executive officer compensation approved with 8,072,067 for, 400,598 against.
- Turnout was 75.71% (11,833,800 of 15,629,463 outstanding shares represented).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661998/000119312526272562/0001193125-26-272562-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661998/000119312526272562/d117360d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-272562

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer